Celastrol and Rhynchophylline in the mitigation of simulated muscle atrophy under in vitro

Muscular atrophy (MA) is a disease of various origins, i.e., genetic or the most common, caused by mechanical injury. So far, there is no universal therapeutic model because this disease is often progressive with numerous manifested symptoms. Moreover, there is no safe and low-risk therapy dedicated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wastag, Maksymilian, Bieżuńska-Kusiak, Katarzyna, Szewczyk, Anna, Szlasa, Wojciech, Grimling, Bożena, Kulbacka, Julita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649342/
https://www.ncbi.nlm.nih.gov/pubmed/36387339
http://dx.doi.org/10.1016/j.jsps.2022.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649342/
https://www.ncbi.nlm.nih.gov/pubmed/36387339
http://dx.doi.org/10.1016/j.jsps.2022.06.008

Ejemplares similares